Amylyx Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
AMLX on Nasdaq
Industry
Pharmaceutical Preparations
Location
43 Thorndike Street, Cambridge, MA

Insiders trading volume in the past year

Amylyx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Isaac Cheng Director $170M Jun 9, 2022
ALS Invest 1 B.V. 10%+ Owner $96.3M Jul 6, 2022
Morningside Venture Investments Ltd 10%+ Owner $81.6M Aug 15, 2023
Justin B. Klee Co-Chief Executive Officer, Director $49.9M -$591K -1.17% Sep 30, 2025
Joshua B. Cohen Co-Chief Executive Officer, Director $49.9M -$590K -1.17% Sep 30, 2025
Dragsa 96 Llc 10%+ Owner $37.6M Jan 11, 2022
Viking Global Investors Lp 10%+ Owner $30.2M Sep 8, 2022
Margaret Olinger Chief Commercial Officer $5.18M Dec 27, 2023
James M. Frates Chief Financial Officer $4.22M -$192K -4.37% Sep 30, 2025
George M. Milne Jr Director $3.36M Jun 5, 2025
Patrick D. Yeramian Chief Medical Officer $3.36M Jan 9, 2024
Camille L. Bedrosian Chief Medical Officer $2.66M -$249K -8.55% Sep 30, 2025
Gina Mazzariello Chief Legal Officer $2.16M -$438K -16.9% Sep 30, 2025
Karen Firestone Director $117K Jun 5, 2025
Bernhardt G. Zeiher Director $37K +$37K Jun 5, 2025
Paul R. Fonteyne Director Jun 5, 2025
Daphne Quimi Director Jun 5, 2025

Recent Insider Transactions by Companies or Individuals for Amylyx Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.